These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7854068)

  • 41. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.
    Souli A; Chariot J; Voisin T; Presset O; Tsocas A; Balasubramaniam A; Laburthe M; Rozé C
    Peptides; 1997; 18(4):551-7. PubMed ID: 9210175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Y1- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus.
    Suzuki N; Okada K; Minami S; Wakabayashi I
    Regul Pept; 1996 Sep; 65(2):145-51. PubMed ID: 8884982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones.
    Illes P; Finta EP; Nieber K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):546-8. PubMed ID: 8114954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
    Grundemar L; Håkanson R
    Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Centrally administered neuropeptide Y delays gastric emptying via Y2 receptors in rats.
    Ishiguchi T; Amano T; Matsubayashi H; Tada H; Fujita M; Takahashi T
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1522-30. PubMed ID: 11641124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S; Corsi M; Rimland JM; Trist DG
    Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
    Browning KN; Travagli RA
    J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
    Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
    Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
    Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line.
    Cox HM; Tough IR
    Br J Pharmacol; 1995 Nov; 116(6):2673-8. PubMed ID: 8590988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptors for peptide YY and neuropeptide Y on guinea pig pancreatic acini.
    Huang SC; Tsai MF
    Peptides; 1994; 15(3):405-10. PubMed ID: 7524045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function.
    Sheikh SP
    Am J Physiol; 1991 Nov; 261(5 Pt 1):G701-15. PubMed ID: 1659217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats.
    Yoneda M; Nakamura K; Yokohama S; Tamori K; Sato Y; Aso K; Aoshima M; Kono T; Makino I
    Hepatology; 1998 Sep; 28(3):670-6. PubMed ID: 9731557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
    Misra S; Mahavadi S; Grider JR; Murthy KS
    Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.